Chris O’Brien, Chief Executive Officer at Biorasi, shared a post by Biorasi on LinkedIn, adding:
“We live in the proverbial “interesting times.” If you work in life sciences, one of the biggest challenges is tracking trends and proof points amidst the blizzard of pronouncements, papers, announcements, etc. that cram our inboxes.
In this episode, I asked past guest, Professor Justin Stebbing, to help us sort the wheat from the chaff. Nobody does it better.
Give it a listen and let us know what you think!”
Quoting Bioarasi‘s post:
“Will GLP1’s one day replace our morning coffee?
Find out in a special video episode of the Biorasi Few and Far Between podcast!
Host Chris O’Brien welcomes friend of the show, Professor Justin Stebbing. In this new segment, we’ll spotlight biotech trends that you need to know about – from T cells to GLP-1 – and identify which innovations are worth the hype.
Watch it today on our YouTube channel.”
More posts featuring Justin Stebbing on OncoDaily.